Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-04-05 Sale |
2021-04-07 5:09 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
3,225 | $189.33 | $610,601 | 88,991 (Direct) |
View |
2021-03-26 Sale |
2021-03-30 6:10 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,894 | $186.8 | $540,609 | 74,670 (Direct) |
View |
2021-03-23 Sale |
2021-03-25 6:41 pm |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
10,000 | $228.22 | $2,282,231 | 59,000 (Indirect Direct) |
View |
2021-03-19 Sale |
2021-03-23 5:33 pm |
NOVAVAX INC | NVAX | MCMANUS MICHAEL A JR Director |
4,000 | $220.78 | $883,110 | 5,951 (Direct) |
View |
2021-03-15 Sale |
2021-03-17 6:36 pm |
NOVAVAX INC | NVAX | EVANS GARY C Director |
24,500 | $211.21 | $5,174,536 | 16,724 (Indirect Direct) |
View |
2021-03-15 Sale |
2021-03-17 6:35 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,267 | $204.84 | $1,693,409 | 152,813 (Direct) |
View |
2021-03-05 Sale |
2021-03-09 7:38 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
3,225 | $163.79 | $528,209 | 92,395 (Direct) |
View |
2021-02-26 Sale |
2021-03-02 5:37 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,895 | $225.48 | $652,759 | 77,564 (Direct) |
View |
2021-02-18 Sale |
2021-02-18 6:59 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,434 | $269.57 | $656,134 | 2,811 (Direct) |
View |
2021-02-16 Sale |
2021-02-18 6:55 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
5,822 | $282.33 | $1,643,709 | 165,778 (Direct) |
View |
2021-02-05 Sale |
2021-02-09 7:40 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
3,224 | $292.51 | $943,041 | 95,799 (Direct) |
View |
2021-02-01 Sale |
2021-02-03 5:37 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
15,022 | $241.5 | $3,627,789 | 80,459 (Direct) |
View |
2021-01-25 Sale(A) |
2021-01-27 6:10 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
73 | $128.6 | $9,388 | 287 (Direct) |
View |
2021-01-25 Sale |
2021-01-27 5:57 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
73 | $128.6 | $9,388 | 287 (Direct) |
View |
2021-01-05 Sale |
2021-01-07 7:08 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CMO and CBO |
17,972 | $112.35 | $2,019,211 | 99,205 (Direct) |
View |
2020-12-31 Sale |
2021-01-05 5:38 pm |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
11,000 | $113.09 | $1,244,015 | 21,500 (Indirect Direct) |
View |
2020-11-16 Sale |
2020-11-18 6:09 pm |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
52,316 | $90.65 | $4,742,667 | 55,677 (Direct) |
View |
2020-09-30 Sale |
2020-10-01 5:40 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
2,250 | $110.22 | $248,002 | 5,087 (Direct) |
View |
2020-09-30 Sale |
2020-10-01 5:39 pm |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
12,233 | $110.23 | $1,348,418 | 20,494 (Direct) |
View |
2020-09-28 Sale |
2020-09-30 9:30 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
42,779 | $109.04 | $4,664,546 | 74,525 (Direct) |
View |
2020-09-28 Sale |
2020-09-30 9:29 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
44,949 | $108.84 | $4,892,300 | 76,561 (Direct) |
View |
2020-09-28 Sale |
2020-09-30 9:28 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
43,568 | $109.04 | $4,750,547 | 96,137 (Direct) |
View |
2020-09-28 Sale |
2020-09-30 9:27 pm |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
30,450 | $110 | $3,349,481 | 182,727 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-04-05 Exercise |
2021-04-07 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
417 | $27.6 | 88,991 (Direct) |
View |
2021-04-05 Exercise |
2021-04-07 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
521 | $46 | 88,991 (Direct) |
View |
2021-04-05 Exercise |
2021-04-07 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
2,083 | $5.95 | 88,991 (Direct) |
View |
2021-04-05 Exercise |
2021-04-07 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
383 | $177.29 | 88,991 (Direct) |
View |
2021-04-05 Exercise |
2021-04-07 5:09 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
3,404 | $0 | 88,991 (Direct) |
View |
2021-04-05 Tax Withholding |
2021-04-07 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
179 | $177.29 | 88,991 (Direct) |
View |
2021-03-26 Exercise |
2021-03-30 6:10 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
416 | $27.6 | 74,670 (Direct) |
View |
2021-03-26 Exercise |
2021-03-30 6:10 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
416 | $46 | 74,670 (Direct) |
View |
2021-03-26 Exercise |
2021-03-30 6:10 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,062 | $5.95 | 74,670 (Direct) |
View |
2021-03-26 Exercise |
2021-03-30 6:10 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,894 | $0 | 74,670 (Direct) |
View |
2021-03-25 Exercise |
2021-03-25 6:41 pm |
N/A N/A |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
10,000 | $27.6 | 59,000 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 6:41 pm |
N/A N/A |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
10,000 | $46 | 59,000 (Direct) |
View |
2021-03-25 Exercise |
2021-03-25 6:41 pm |
N/A N/A |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
37,500 | $3.985 | 59,000 (Direct) |
View |
2021-03-23 Exercise |
2021-03-25 6:41 pm |
2019-12-13 2028-12-13 |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
57,500 | $0 | 59,000 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:36 pm |
N/A N/A |
NOVAVAX INC | NVAX | EVANS GARY C Director |
2,000 | $99.8 | 16,724 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:36 pm |
N/A N/A |
NOVAVAX INC | NVAX | EVANS GARY C Director |
4,500 | $46 | 16,724 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:36 pm |
N/A N/A |
NOVAVAX INC | NVAX | EVANS GARY C Director |
18,000 | $3.985 | 16,724 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:36 pm |
2016-09-15 2026-03-15 |
NOVAVAX INC | NVAX | EVANS GARY C Director |
24,500 | $0 | 16,724 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:35 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
868 | $27.6 | 152,813 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:35 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
4,819 | $217.46 | 152,813 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:35 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,101 | $46 | 152,813 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:35 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
3,124 | $5.95 | 152,813 (Direct) |
View |
2021-03-15 Tax Withholding |
2021-03-17 6:35 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,264 | $217.46 | 152,813 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:35 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
619 | $27 | 152,813 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 6:35 pm |
N/A 2026-11-14 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
10,531 | $0 | 152,813 (Direct) |
View |
2021-03-05 Exercise |
2021-03-09 7:38 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
417 | $27.6 | 92,395 (Direct) |
View |
2021-03-05 Exercise |
2021-03-09 7:38 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
521 | $46 | 92,395 (Direct) |
View |
2021-03-05 Exercise |
2021-03-09 7:38 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
2,466 | $5.95 | 92,395 (Direct) |
View |
2021-03-05 Tax Withholding |
2021-03-09 7:38 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
179 | $174.84 | 92,395 (Direct) |
View |
2021-03-05 Exercise |
2021-03-09 7:38 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
3,404 | $0 | 92,395 (Direct) |
View |
2021-02-26 Exercise |
2021-03-02 5:37 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
416 | $27.6 | 77,564 (Direct) |
View |
2021-02-26 Exercise |
2021-03-02 5:37 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
416 | $46 | 77,564 (Direct) |
View |
2021-02-26 Exercise |
2021-03-02 5:37 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,063 | $5.95 | 77,564 (Direct) |
View |
2021-02-26 Exercise |
2021-03-02 5:37 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,895 | $0 | 77,564 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 6:55 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
868 | $27.6 | 165,778 (Direct) |
View |
2021-02-16 Tax Withholding |
2021-02-18 6:55 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,275 | $262.7 | 165,778 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 6:55 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,101 | $46 | 165,778 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 6:55 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
7,943 | $5.95 | 165,778 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 6:55 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
619 | $27 | 165,778 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 6:55 pm |
N/A 2026-11-14 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
10,531 | $0 | 165,778 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 7:40 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
417 | $27.6 | 95,799 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 7:40 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
521 | $46 | 95,799 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 7:40 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
2,468 | $5.95 | 95,799 (Direct) |
View |
2021-02-05 Tax Withholding |
2021-02-09 7:40 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
182 | $290.18 | 95,799 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 7:40 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
3,406 | $0 | 95,799 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 5:37 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,085 | $27.6 | 80,459 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 5:37 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,080 | $46 | 80,459 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 5:37 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
8,249 | $5.95 | 80,459 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 5:37 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,608 | $27 | 80,459 (Direct) |
View |
2021-02-01 Exercise |
2021-02-03 5:37 pm |
N/A 2026-11-14 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
15,022 | $0 | 80,459 (Direct) |
View |
2021-01-05 Tax Withholding(A) |
2021-01-27 5:55 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, Chief Commercial Officer |
511 | $116.24 | 866 (Direct) |
View |
2021-01-05 Exercise |
2021-01-07 7:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CMO and CBO |
1,668 | $27.6 | 99,205 (Direct) |
View |
2021-01-05 Exercise |
2021-01-07 7:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CMO and CBO |
2,082 | $46 | 99,205 (Direct) |
View |
2021-01-05 Exercise |
2021-01-07 7:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CMO and CBO |
7,398 | $5.95 | 99,205 (Direct) |
View |
2021-01-05 Exercise |
2021-01-07 7:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CMO and CBO |
2,608 | $27 | 99,205 (Direct) |
View |
2021-01-05 Tax Withholding |
2021-01-07 7:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CMO and CBO |
584 | $116.24 | 99,205 (Direct) |
View |
2021-01-05 Exercise |
2021-01-07 7:08 pm |
N/A 2026-11-14 |
NOVAVAX INC | NVAX | Trizzino John EVP, CMO and CBO |
13,756 | $0 | 99,205 (Direct) |
View |
2020-12-31 Exercise |
2021-01-05 5:42 pm |
2011-09-10 2021-03-10 |
NOVAVAX INC | NVAX | DOUGLAS RICHARD Director |
1,000 | $0 | 28,500 (Direct) |
View |
2020-12-31 Exercise |
2021-01-05 5:42 pm |
N/A N/A |
NOVAVAX INC | NVAX | DOUGLAS RICHARD Director |
1,000 | $50 | 28,500 (Direct) |
View |
2020-12-31 Exercise |
2021-01-05 5:38 pm |
N/A N/A |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
10,000 | $51.4 | 21,500 (Direct) |
View |
2020-12-31 Exercise |
2021-01-05 5:38 pm |
2011-09-10 2021-03-10 |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
21,000 | $0 | 21,500 (Direct) |
View |
2020-12-31 Exercise |
2021-01-05 5:38 pm |
N/A N/A |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
1,000 | $50 | 21,500 (Direct) |
View |
2020-12-14 Option Award |
2020-12-16 5:11 pm |
N/A 2030-12-14 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
19,000 | $0 | 19,000 (Direct) |
View |
2020-12-14 Option Award |
2020-12-16 5:09 pm |
N/A 2030-12-14 |
NOVAVAX INC | NVAX | Trizzino John EVP, CMO and CBO |
14,300 | $0 | 14,300 (Direct) |
View |
2020-12-14 Option Award |
2020-12-16 5:08 pm |
N/A 2030-12-14 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
28,000 | $0 | 28,000 (Direct) |
View |
2020-12-14 Option Award |
2020-12-16 5:06 pm |
N/A 2030-12-14 |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
62,600 | $0 | 62,600 (Direct) |
View |
2020-12-07 Option Award |
2020-12-09 6:01 pm |
2021-12-07 2030-12-07 |
NOVAVAX INC | NVAX | MCGLYNN MARGARET G Director |
7,700 | $0 | 7,700 (Direct) |
View |
2020-12-05 Option Award |
2020-12-08 6:21 pm |
N/A N/A |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
20,000 | $0 | 20,000 (Direct) |
View |
2020-11-16 Exercise |
2020-11-18 6:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
9,818 | $25.6 | 55,677 (Direct) |
View |
2020-11-16 Exercise |
2020-11-18 6:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
42,499 | $39.8 | 55,677 (Direct) |
View |
2020-11-16 Exercise |
2020-11-18 6:09 pm |
N/A 2021-06-22 |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
52,317 | $0 | 55,677 (Direct) |
View |
2020-11-16 Option Award |
2020-11-18 6:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | COVINO GREGORY F EVP, Chief Financial Officer |
15,500 | $0 | 15,500 (Direct) |
View |
2020-10-31 Option Award |
2020-11-03 6:15 pm |
2021-10-31 2030-10-31 |
NOVAVAX INC | NVAX | Alton Gregg H Director |
7,700 | $0 | 7,700 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:30 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
24,750 | $5.95 | 74,525 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:30 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
24,750 | $0 | 74,525 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:29 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
25,000 | $5.95 | 76,561 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:29 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
25,000 | $0 | 76,561 (Direct) |
View |
2020-09-28 Tax Withholding |
2020-09-30 9:28 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
2,103 | $111.18 | 96,137 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:28 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
29,600 | $5.95 | 96,137 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:28 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
29,600 | $0 | 96,137 (Direct) |
View |
2020-09-28 Tax Withholding |
2020-09-30 9:27 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
11,429 | $111.18 | 182,727 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:27 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
25,000 | $5.95 | 182,727 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:27 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
50,000 | $0 | 182,727 (Direct) |
View |
2020-09-26 Tax Withholding |
2020-09-29 6:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
2,434 | $113.56 | 37,698 (Direct) |
View |
2020-09-26 Exercise |
2020-09-29 6:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
6,546 | $0 | 37,698 (Direct) |
View |
2020-09-26 Tax Withholding |
2020-09-29 6:15 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
17,117 | $113.56 | 30,484 (Direct) |
View |
2020-09-26 Exercise |
2020-09-29 6:15 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
35,438 | $0 | 30,484 (Direct) |
View |
2020-09-26 Tax Withholding |
2020-09-29 6:12 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
18,639 | $113.56 | 21,510 (Direct) |
View |
2020-09-26 Exercise |
2020-09-29 6:12 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
38,588 | $0 | 21,510 (Direct) |
View |
2020-09-26 Tax Withholding |
2020-09-29 6:11 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
16,844 | $113.56 | 26,250 (Direct) |
View |
2020-09-26 Exercise |
2020-09-29 6:11 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
34,873 | $0 | 26,250 (Direct) |
View |